Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Purchased by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC increased its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 139.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 117,291 shares of the pharmacy operator’s stock after purchasing an additional 68,242 shares during the period. Tower Research Capital LLC TRC’s holdings in Walgreens Boots Alliance were worth $3,062,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Dark Forest Capital Management LP lifted its stake in shares of Walgreens Boots Alliance by 6.5% in the 3rd quarter. Dark Forest Capital Management LP now owns 29,409 shares of the pharmacy operator’s stock worth $654,000 after acquiring an additional 1,804 shares during the period. Quadrant Capital Group LLC lifted its stake in shares of Walgreens Boots Alliance by 33.8% in the 4th quarter. Quadrant Capital Group LLC now owns 7,494 shares of the pharmacy operator’s stock worth $196,000 after acquiring an additional 1,893 shares during the period. New York Life Investment Management LLC lifted its stake in shares of Walgreens Boots Alliance by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 115,196 shares of the pharmacy operator’s stock worth $3,008,000 after acquiring an additional 690 shares during the period. Deutsche Bank AG lifted its stake in shares of Walgreens Boots Alliance by 36.2% in the 3rd quarter. Deutsche Bank AG now owns 2,170,347 shares of the pharmacy operator’s stock worth $48,269,000 after acquiring an additional 576,534 shares during the period. Finally, Van ECK Associates Corp lifted its stake in shares of Walgreens Boots Alliance by 28.2% in the 3rd quarter. Van ECK Associates Corp now owns 129,191 shares of the pharmacy operator’s stock worth $2,873,000 after acquiring an additional 28,400 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ WBA opened at $15.84 on Friday. The company has a market cap of $13.67 billion, a PE ratio of -2.26, a price-to-earnings-growth ratio of 0.99 and a beta of 0.78. Walgreens Boots Alliance, Inc. has a 12 month low of $14.62 and a 12 month high of $32.89. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32. The company has a 50-day simple moving average of $17.43 and a 200-day simple moving average of $20.79.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. During the same period in the previous year, the firm posted $1.16 earnings per share. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. On average, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.21 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be given a $0.25 dividend. The ex-dividend date of this dividend is Monday, May 20th. This represents a $1.00 annualized dividend and a dividend yield of 6.31%. Walgreens Boots Alliance’s dividend payout ratio is presently -14.29%.

Insider Buying and Selling

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Manmohan Mahajan acquired 6,000 shares of the company’s stock in a transaction dated Tuesday, April 2nd. The shares were purchased at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the purchase, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The disclosure for this purchase can be found here. Corporate insiders own 17.40% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. TD Cowen reduced their target price on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a research note on Wednesday, April 3rd. UBS Group reduced their target price on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a research note on Wednesday, April 3rd. Bank of America cut their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a report on Tuesday, March 26th. Morgan Stanley cut their price target on shares of Walgreens Boots Alliance from $16.00 to $13.00 and set an “underweight” rating for the company in a report on Friday, May 31st. Finally, Leerink Partnrs reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Monday, February 26th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $23.57.

View Our Latest Research Report on WBA

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

See Also

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.